Rhodococcus equi is a Gram‐positive, facultative intracellular bacterium which infects macrophages and causes rhodococcal pneumonia and enteritis in foals. Recently, this agent has been recognized as an opportunistic pathogen for immunocompromised humans. Several murine experimental models have been used to study R. equi infection. High (HIV‐A) and Low (LIV‐A) antibody (Ab)‐producers mice were obtained by bi‐directional genetic selections for their ability to produce antibodies against sheep and human erythrocytes (Selection IV‐A). These lines maintain their phenotypes of high and low responders also for other antigens than those of selection (multispecific effect). A higher macrophage activity in LIV‐A mice has been described for several intracellular infectious agents, which could be responsible for their intense macrophage antigens (Ag)‐handling and low Ab production. Due to these differences, LIV‐A mice were found to exhibit a better performance to trigger an effective immune response towards intracellular pathogens. The objective of this work was to characterize the immune response of Selection IV‐A against R. equi. HIV‐A and LIV‐A mice were infected with 2.0 ×106 CFU of ATCC 33701+R. equi by intravenous route. With regards to bacterial clearance and survival assays, LIV‐A mice were more resistant than HIV‐A mice to virulent R. equi. LIV‐A mice presented a higher hydrogen peroxide (H2O2) and nitric oxide (NO) endogenous production by splenic macrophages than HIV‐A mice. LIV‐A expressed the most intense cellular response, available by the Delayed‐Type Hypersensitivity (DTH) reaction, which activated macrophages and produced more H2O2 and NO. The three times higher specific antibodies titres in HIV‐A indicated that Selection IV‐A maintained the multispecific effect and the polygenic control of humoral and cellular responses also to R. equi.